Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.

Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.

<h4>Background</h4>Xpert MTB/RIF (Xpert) was piloted in Kazakhstan to detect tuberculosis (TB) and rifampicin resistance (RR-)TB among individuals at risk of multidrug-resistant (MDR-) TB. This study assessed the performance of Xpert compared to conventional diagnostic methods, RR-TB cas...

Full description

Bibliographic Details
Main Authors: Sanne Christine van Kampen, Aigul Tursynbayeva, Aliya Koptleuova, Zauresh Murzakhmetova, Lyazzat Bigalieva, Moldir Aubakirova, Svetlana Pak, Susan van den Hof
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0132514

Internet

https://doi.org/10.1371/journal.pone.0132514

Similar Items